{"entity":{"id":"nct07559760","kind":"trial","name":"New Second-Line Combo Therapy for MSS Metastatic Colorectal Cancer","aka":[],"tldr":"A phase 2 trial of bevacizumab (glioblastoma use) in colorectal cancer, run by The First Hospital of Jilin University, now recruiting.","summary":"New Second-Line Combo Therapy for MSS Metastatic Colorectal Cancer is a phase 2, interventional study registered as NCT07559760 by The First Hospital of Jilin University, with a registry enrolment figure of 30 participants, started 2025-11-01 and due to reach its primary completion in 2027-05-31. Interventions recorded: Levofolinic Acid + 5-FU continuous infusion + irinotecan HCl liposome ± cetuximab/bevacizumab. Conditions listed: Metastatic Colorectal Cancer. Primary outcome: mPFS. Colorectal eligibility wording from the registry: \"Histologically or cytologically confirmed colorectal adenocarcinoma\". Sites: China. No results are recorded here; the registry entry is the source.","status":"recruiting","asOf":"2026-09-24","links":[{"label":"ClinicalTrials.gov NCT07559760","url":"https://clinicaltrials.gov/study/NCT07559760"}],"tags":["ctgov-ingest","colorectal-deep-dive"],"related":[],"cancers":["rectal-cancer","colon-cancer"],"sections":[],"technologies":[],"targets":[],"drugs":["bevacizumab-glioma"],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT07559760","phase":"2","setting":"A Prospective Study of Levoleucovorin/5-FU Co-Infusion Combined With Liposomal Irinotecan ±Cetuximab/Bevacizumab as Second-Line Therapy for MSS Metastatic Colorectal Cancer","sponsor":"The First Hospital of Jilin University","enrolled":30,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct07559760/","neighbours":{"cancer":[{"id":"colon-cancer","kind":"cancer","name":"Colon cancer (adenocarcinoma of the colon)","route":"/cancers/colon-cancer/"},{"id":"rectal-cancer","kind":"cancer","name":"Rectal cancer","route":"/cancers/rectal-cancer/"}],"drug":[{"id":"bevacizumab-glioma","kind":"drug","name":"Bevacizumab (glioblastoma use)","route":"/drugs/bevacizumab-glioma/"}],"term":[{"id":"colorectal-trials-open-today","kind":"term","name":"Colorectal cancer trials open today (registry snapshot)","route":"/terms/colorectal-trials-open-today/"}]}}